Norethisterone acetate, also known as norethindrone acetate and sold under the brand name Primolut-Nor among others, is a progestin medication which is used in birth control pills, menopausal hormone therapy, and for the treatment of gynecological disorde + some more technical info. Chemically it is the 17-acetate ester of norethisterone, acting as a progesterone receptor agonist that suppresses gonadotropin release, alters endometrial receptivity, and modifies cervical mucus. It is formulated for oral use in micronized tablet forms and in combination with estrogens for combined oral contraceptives or menopausal regimens. Key pharmacokinetic points are rapid absorption, hepatic metabolism mainly by reduction and conjugation, and systemic exposure influenced by first-pass metabolism; ester hydrolysis yields active norethisterone. Typical clinical dose ranges and regimens vary by indication, with safety monitoring focusing on thromboembolic risk factors, liver function, and menstrual bleeding patterns.
Parent: Norethisterone Acetate
Parent: Norethisterone Acetate
Parent: Norethisterone Acetate / Norethisterone
![(8R,9S,10R,13S,14S,16S,17S)-17-ethynyl-13-methyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diyl diacetate](https://veeprho.com/wp-content/uploads/2024/02/Norethisterone-acetate-Enol-Ester-Impurity.png "(8R,9S,10R,13S,14S,16S,17S)-17-ethynyl-13-methyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diyl diacetate")
Parent: Norethisterone Acetate
![(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-6,17-diyl diacetate](https://veeprho.com/wp-content/uploads/2024/02/Norethisterone-acetate-Impurity-O.png "(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-6,17-diyl diacetate")
Parent: Norethisterone Acetate
![(8R,9S,10R,13S,14S,17R)-3,17-diethynyl-13-methyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate](https://veeprho.com/wp-content/uploads/2024/02/Norethisterone-acetate-Impurity-K.png "(8R,9S,10R,13S,14S,17R)-3,17-diethynyl-13-methyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate")
Parent: Norethisterone Acetate
Typical quality control specifications for norethisterone acetate active pharmaceutical ingredient define assay and impurity limits to ensure product safety and consistency: assay by HPLC commonly specified around 98.0 to 102.0 percent on a dried basis; total related impurities generally limited to not more than 1.5 to 2.0 percent by area; any individual unspecified impurity controlled to not exceed 0.5 percent; known related compounds are monitored with tighter limits, for example the deacetylation product norethisterone (norethindrone) often specified at not more than 0.2 to 0.5 percent, oxidation and epimerization products controlled typically below 0.1 to 0.3 percent each. Residual solvents such as methanol and ethanol are limited in accordance with ICH Q3C guidelines (for example methanol often limited to 3000 ppm), and heavy metals and microbial limits are set per relevant pharmacopeial monographs. These ranges represent common manufacturer specifications and should be confirmed against the finished product monograph or regulatory dossier for a given supplier.
Norethisterone acetate is used as a progestin in combined and progestogen-only contraceptives, for short-term control of heavy or irregular menstrual bleeding, to delay menstruation, and as part of menopausal hormone therapy regimens; it is also used in various gynecological conditions where progestogenic action is indicated, with treatment regimens and doses determined by the specific indication.
Stopping norethisterone can lead to withdrawal bleeding, return of ovulatory cycles and fertility, recurrence of the original symptoms being treated such as heavy or irregular bleeding, and transient hormonal symptoms including mood changes, breast tenderness, or acne; if norethisterone was suppressing ovulation or bleeding, those processes typically resume within one to a few menstrual cycles.
Norethisterone is the free 17-hydroxy steroid (an active progestin) while norethisterone acetate is its 17-acetate ester; the acetate functions as an esterified prodrug that can alter absorption and prolong systemic exposure because it requires hydrolysis to the parent alcohol, leading to modest differences in pharmacokinetics and dosing, though both compounds exert progestogenic effects after conversion to the active form.
Norethindrone acetate can suppress menstrual bleeding when given continuously or used in higher short-term doses to delay menses, but response varies by regimen and individual; on typical cyclic regimens withdrawal bleeding will occur when the drug is stopped, whereas continuous administration may reduce or eliminate periodic bleeding for many patients.
